SciHub
文献互助
期刊查询
一搜即达
科研导航
即时热点
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!
车念波
Lv1
10 积分
2022-04-07 加入
最近求助
最近应助
互助留言
Adjuvant chemotherapy and hormonotherapy versus adjuvant hormonotherapy alone for women aged 70 years and older with high-risk breast cancer based on the genomic grade index (ASTER 70s): a randomised phase 3 trial
5小时前
待确认
Weight Changes and Heart Failure Risk After Breast Cancer Development
29天前
已完结
Endocrine Therapy Omission in Estrogen Receptor–Low (1%-10%) Early-Stage Breast Cancer
2个月前
已完结
Human Epidermal Growth Factor Receptor 2 Loss Following Treatment with Trastuzumab Deruxtecan in Patients with Metastatic Breast Cancer
2个月前
已完结
6th and 7th International consensus guidelines for the management of advanced breast cancer (ABC guidelines 6 and 7)
2个月前
已完结
Effect of Capecitabine Maintenance Therapy Using Lower Dosage and Higher Frequency vs Observation on Disease-Free Survival Among Patients With Early-Stage Triple-Negative Breast Cancer Who Had Received Standard Treatment
2个月前
已完结
Topical Diclofenac for Prevention of Capecitabine-Associated Hand-Foot Syndrome: A Double-Blind Randomized Controlled Trial
3个月前
已完结
Pregnancy After Breast Cancer in Patients With Germline BRCA Mutations
3个月前
已完结
Prevention of sacituzumab govitecan (SG)-related neutropenia and diarrhea in patients (pts) with triple-negative or HR+/HER2- advanced breast cancer (ABC; PRIMED): A phase 2 trial
8个月前
已完结
346MO Trastuzumab deruxctecan (T-DXd) associated interstitial lung disease (ILD) in a large real-world French cohort of patients with HER2-driven breast cancer and other malignancies
8个月前
已关闭
没有进行任何应助
感谢
3个月前
感谢
3个月前
感谢
10个月前
感谢
1年前
谢谢
1年前
感谢
1年前
感谢!!!
1年前
感谢
1年前
感谢
1年前
感谢,速度真快
1年前
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论